Inflammatory bowel disease and pregnancy: Evidence, uncertainty and patient decision-making

Canadian Journal of Gastroenterology

Volumn 23, Issue 1, 2009, Pages 49-53

  Habal, Flavio M ^a   Kapila, Varun ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biologics; Bowel; Inflammatory; Management; Pregnancy; Therapy

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

BIOLOGICAL THERAPY; CHILD CARE; CONGENITAL DISORDER; CROHN DISEASE; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ENDOSCOPY; ENTERITIS; EVIDENCE BASED PRACTICE; FEMALE INFERTILITY; FETUS OUTCOME; GESTATION PERIOD; HEREDITY; HUMAN; HYPEREMESIS GRAVIDARUM; MATERNAL CARE; MATERNAL HYPERTENSION; PATIENT COUNSELING; PATIENT DECISION MAKING; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; SPONTANEOUS ABORTION; ULCERATIVE COLITIS; UNCERTAINTY;

EID: 60849100223     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/531638     Document Type: Review

References (40)

1. Orholm M, Binder V, Sørensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-81.
2. Tysk C, Lindberg E, Järnerot G, Flodérus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.
3. Yang H, McElree C, Roth MP, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: Differences between Jews and non-Jews. Gut 1993;34:517-24.
4. Steinlauf AF, Present DH. Medical management of the pregnant patient with inflammatory bowel disease. Gastroenterol Clin North Am 2004;33:361-85.
5. Gorgun E, Remzi FH, Goldberg JM, et al. Fertility is reduced after restorative proctocolectomy with ileal pouch anastomosis: A study of 300 patients. Surgery 2004;136:795-803.
6. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984;25:52-6.
7. Subhani JM, Hamilton MI. Review article: The management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998;12:1039-53.
8. Bush MC, Patel S, Lapinski RH, Stone JL. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004;15:237-41.
9. Mottet C, Juillerat P, Gonvers J, et al. Pregnancy and Crohn's disease. Digestion 2005;71:54-61.
10. Dejaco C, Angelberger S, Waldhoer T, et al. Risk factors for pregnancy outcome in patients with inflammatory bowel disease (IBD). Gastroenterology 2006;130 Suppl 2:A-39(Abst).
11. Carter MJ, Lobo AJ, Travis SPL; IBD Section, British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004;53(Suppl V):V1-16.
12. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: A large community-based study from Northern California. Gastroenterology. 2007;133:1106-12
13. Cornish J, Tan E, Teare J, et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007;56:830-7.
14. Cappell MS, Colon V, Sidhom OA. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison control groups. Am J Gastroenterol 1996; 91:348-54.
15. Qureshi WA, Rajan E, Adler DG, et al. ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2005;61:357-62.
16. Neissner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-35.
17. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443-6.
18. Francella A, Dyan A, Bodian C, Rubits P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003;124:9-17.
19. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity. Ann Intern Med 1989;111:641-9.
20. Chow M, Koo J, Ng P, Rubin H. Random population-wide genetic damage induced in replicating cells treated with methotrexate. Mutat Res 1998;413:251-64.
21. Kremer JM. Toward a better understanding of methotrexate. Arthritis Rheum 2004;50:1370-82.
22. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005;35:112-21.
23. Moskovitz DN, Bodian C, Chapman ML, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 2004;656-61.
24. Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004;2:731-43.
25. Mahadevan U, Corley D. Aminosalicylate (ASA) use during pregnancy is not associated with increased adverse events or congenital malformations (CM) in women with inflammatory bowel disease (IBD). Gastroenterology 2006;130(Suppl 2):A-40 (Abst).
26. Nyberg G, Haljamae U, Frisenette-Fich C, Wennergen M, Kjellmer I. Breast-feeding during treatment with cyclosporine. Transplantation 1998;65:253-5.
27. Grekas DM, Vasiliou SS, Lazarides AN. Immunosuppressive therapy and breast feeding after renal transplantation. Nephron 1984;37:68.
28. Danesi R, Del Tacca M. Teratogenesis and immunosuppressive treatment. Transplant Proc 2004;36:705-7.
29. Daher S, Fonseca F, Ribiero OG, et al. Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 1999;83:77-9.
30. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006;4:1255-8.
31. Skomsvoll JF, Wallenius M, Koksvik HS, et al. Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat Clin Pract Rheumatol 2007;3:156-64.
32. Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF) therapy. Rheumatology (Oxford) 2007;46:695-8.
33. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving jnfliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004;99:2385-92.
34. Mahadevan U, Kane S, Sandborn WJ, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005;21:733-38.
35. Stengel J, Arnold HL. Is Infliximab safe to use while breastfeeding? World J Gastroentorol 2008;14:3085-7.
36. Ostensen M, Eigenmann GO. Etanercept in breast milk. J Rheumatol 2004;31:1017-8
37. Mottet C, Juillerat P, Pittet V, et al. Pregnancy and breastfeeding us patients with Crohn's disease. Digestion 2007;76:149-60
38. Woolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum 1990;33:869-73.
39. Agret F, Cosnes J, Hassani Z, et al. Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther 2005;21:509-13.
40. Kane S, Lemieux N. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005;100:102-5.